Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-11

Clinical Trial Update: Hip Viscosupplementation: What is the Best Dosage? [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring the optimal dosage of hip viscosupplementation for osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viscosupplementation

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Osteoarthritis | Phase 4 | Status: UNKNOWN